📉 ICYMI: Novo Nordisk and Eli Lilly are yo-yoing

Plus, how to build a thematic portfolio | [Finimize]( In Case You Missed It… Not long ago, weight-loss-drug stocks looked as expensive as the medicinal pens they sell. But now, they’re on something of a slimmers’ diet. So if you want to invest in the sector – or in any theme, for that matter – you’ll need to know when to pounce, and how. [The Yo-Yo Stock Gains And Losses Of Novo Nordisk and Eli Lilly]( The weight-loss drug market has pushed these pharma giants to stunning valuations. But after their recent dip, Russell says, it may be time to check them out. [Find out if the weight-loss-drug stocks are a bargain or a bust now.]( [AI, Nutrition, And Everything In Between: Five Rules For Building A Thematic Portfolio]( Thematic investing has been a hot topic this year, with investors won over by trends like AI and weight-loss pharmaceuticals. Here’s how to do it right. [Get five pointers on building a portfolio you can truly back.]( [Active Versus Passive Investing: Which Is Better?]( Strategists often disagree on the merits of active investing vs passive investing. Learn the benefits and drawbacks of each with our expert investment advice. [Discover whether the extra risk and work would be worth it for you.]( [The US Economy Is Being Pulled In Two Directions Right Now]( One force is pushing upward and the other is pushing downward. Here’s what to do about that. [See which force could be the most dominant: upward, or downward.]( 🎙 finimize live [How To Invest Like A Modern Warren Buffett]( [How To Invest Like A Modern Warren Buffett]( Buffett’s theory is easy to understand: find high-potential companies trading at a decent value. But that’s harder to pull off in practice – unless you have the experts ready to walk you through. 🌎 Global • Wed, Aug 14th [Get Tickets]( You stay classy, {NAME} 😉 [Turn off these emails]( or [unsubscribe]( from all Finimize Emails including the Daily Brief. Crafted by Finimize Ltd. | 280 Bishopsgate, London, EC2M 4AG [View in browser](